People · Operator

CRAIG RANDALL

Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology

1
Companies
1
Filings
$50.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Superluminal Medicines, Inc.—BiotechnologySeries B$50.7M$22.1M2023
Operator network

CRAIG RANDALL at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

ANDREW LEVIN · 17 companies · 1 sharedANDREW LEVINDylan Morris · 8 companies · 1 sharedDylan MorrisCATHERINE RIESEN · 2 companies · 1 sharedCATHERINE RIESENCONY D'CRUZ · 2 companies · 1 sharedCONY D'CRUZDIAMANTIS XYLAS · 2 companies · 1 sharedDIAMANTIS XYLASSuperluminal Medicines, Inc. · $50.7M raisedSuperluminal Medicine…CRAIG RANDALLCR
CRAIG RANDALL Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside CRAIG RANDALL on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
ANDREW LEVIN117
Dylan Morris18
DIAMANTIS XYLAS12
CONY D'CRUZ12
CATHERINE RIESEN12

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.